INS and fatty liver disease: Some features of IR and HI such as increased hepatic glucose production are likely a consequence of reduced insulin action, while others such as hepatic steatosis and dyslipidemia are likely due to increased insulin action via signaling pathways that are not perturbed in IR (4, 5).